1.請各位教職員生務必依照校方規定撰寫作者單位，以利申請校級論文獎勵金以及醫學科技學院論文獎勵金。(校級論文獎勵金申請資格請參照研發處規定辦理。) 2.院級論文獎勵金審查，未來如未依照校方規定撰寫作者單位，將取消該篇論文之獎勵金申請資格。(本審查規定經2020.07.27(一)1082醫科院第七次院務會議決議通過)

7/3中午醫科院與預備升等的教師們針對爭議性期刊論文的討論會圓滿落幕，感謝參與的所有老師。討論會上和與會教師們達成升等論文計分共識，今年起會陸續新訂/增修本院升等審查條文並公告。其他教師升等規定，請依校方辦法為準則辦理。

依2023.07.03召開之醫科院爭議性期刊論文的討論會共識： 1.掠奪性期刊即日起一律禁止所有態樣使用/認列。 2.博士論文畢業條件與巨量期刊Mega Journal相關規範依校級會議決議執行： (A)舊生設立兩年緩衝期，兩年後發表於Mega Journal之論文將不得列為畢業論文。 (B)自112學年度起入學新生全面實施發表於Mega Journal之論文不得列為畢業論文，請各學院與新生充份溝通並於新生說明會宣導。

1122學期醫學科技學院永信藥品實習甄選錄取名單公告

2024.06.07 (W5) 14:00-16:00，Special Lecture on Cancer genomics & proteomics：Epigenetics and Beyond: Targeting the histone-modifying enzymes in cancer and disease.. @ Shuang-Ho Campus, Teaching & Research Building, 8F Meeting Room 3.

H1 Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus Hepatitis C Virus Infection.

E2 E3 Ubiquitin enzyme pairing partnership in provoking or mitigating cancers

Injectable Bioactive Glass/Sodium Alginate Hydrogel with Immunomodulatory and Angiogenic Properties for Enhanced Tendon Healing

Genetic Disruption of KLF1 K74 SUMOylation in Hematopoietic System1 Promotes Healthy Longevity in Mice

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma

Using artificial intelligence based models to predict the risk of mucormycosis among COVID 19 survivors: An experience from a public hospital in India

Long noncoding RNA Smyca coactivates TGF β/ Smad and Myc pathways to drive tumor progression

Ribonucleotide reductase M2B in the myofibers modulates stem cell fate in skeletal muscle

2022.12.05(Mon) 09:00-12:00 「2022 TMU-NHRI-NIH Neuroscience Symposium-Neurodegenerative Disorders」